FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

27991611000001107: Potassium permanganate 400mg tablets for cutaneous solution (Ennogen Pharma Ltd) (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 28-Nov 2018. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    87585501000001111 Potassium permanganate 400mg tablets for cutaneous solution (Ennogen Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    87585601000001110 Potassium permanganate 400mg tablets for cutaneous solution (Ennogen Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Potassium permanganate 400mg tablets for cutaneous solution (Ennogen Pharma Ltd) Is a Potassium permanganate 400mg tablet for solution false Inferred relationship Existential restriction modifier
    Potassium permanganate 400mg tablets for cutaneous solution (Ennogen Pharma Ltd) Has active ingredient Potassium permanganate false Inferred relationship Existential restriction modifier
    Potassium permanganate 400mg tablets for cutaneous solution (Ennogen Pharma Ltd) Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
    Potassium permanganate 400mg tablets for cutaneous solution (Ennogen Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Potassium permanganate 400mg tablets for cutaneous solution (Ennogen Pharma Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Potassium permanganate 400mg tablets for cutaneous solution (Ennogen Pharma Ltd) Has specific active ingredient Potassium permanganate false Inferred relationship Existential restriction modifier
    Potassium permanganate 400mg tablets for cutaneous solution (Ennogen Pharma Ltd) Has dispensed dose form Tablet for conventional release cutaneous solution false Inferred relationship Existential restriction modifier
    Potassium permanganate 400mg tablets for cutaneous solution (Ennogen Pharma Ltd) Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
    Potassium permanganate 400mg tablets for cutaneous solution (Ennogen Pharma Ltd) Is a Actual medicinal product false Inferred relationship Existential restriction modifier
    Potassium permanganate 400mg tablets for cutaneous solution (Ennogen Pharma Ltd) Is a Potassium permanganate 400mg tablets for cutaneous solution false Inferred relationship Existential restriction modifier
    Potassium permanganate 400mg tablets for cutaneous solution (Ennogen Pharma Ltd) Is a Potassium permanganate 400mg tablets for cutaneous solution false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Potassium permanganate 400mg tablets for cutaneous solution (Ennogen Pharma Ltd) 30 tablet Has AMP False Potassium permanganate 400mg tablets for cutaneous solution (Ennogen Pharma Ltd) Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start